22nd Century Group Inc (XXII)

[Canna_Business]

10/21/20 - 11:15 a.m. ET. (FDA Update)

“I am delighted to participate in this important conference and to support, with our reduced nicotine technology, FDA’s plan to implement a reduced nicotine product standard."

“The science is clear. By limiting the nicotine content of all combustible cigarettes to levels achieved in our VLN® cigarettes, the FDA projects that five million adult smokers would quit one year after implementation and over eight million American lives would be saved by the end of the century. Our goal for this conference, as in general, is to advance common-sense tobacco and nicotine regulation and unite against the tragic toll of cigarette addiction to improve public health in America.”

"Mitchell R. Zeller, director of the Center for Tobacco Products (CTP) at the U.S. Food and Drug Administration (FDA), will provide an update on the FDA’s Comprehensive Plan for Tobacco and Nicotine Products at the Food and Drug Law Institute’s (FDLI) Tobacco and Nicotine Products Regulation and Policy Conference on Wednesday October 21, 2020 at 11:15 a.m. ET."

"22nd Century believes that the FDA is in the final stages of its decision-making process for the Company’s Modified Risk Tobacco Product (MRTP) Applications for VLN®."

Article:
https://www.xxiicentury.com/news-media/press-releases/detail/401/22nd-century-group-to-highlight-its-reduced-nicotine